COVID-19 vaccine Archives | Be Korea-savvy
N. Korea’s Media Shifts Stance, Questions Effectiveness of COVID-19 Vaccines

N. Korea’s Media Shifts Stance, Questions Effectiveness of COVID-19 Vaccines

SEOUL, May 24 (Korea Bizwire) — North Korea’s state-controlled media carried reports Tuesday questioning the usefulness of COVID-19 vaccines, as the secretive nation has claimed progress in efforts to control the virus outbreak. The North’s latest stance may suggest a dimmer prospect of accepting the international community’s existing offers of vaccine aid, including Washington’s stated [...]

New Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to Help Meet Country Demand for COVID-19 Vaccines

New Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to Help Meet Country Demand for COVID-19 Vaccines

New York, April 7 (Korea Bizwire) – MedAccess, the Open Society Foundations, and Gavi, the Vaccine Alliance today announced a new partnership to create a Risk Sharing Facility to help countries procure additional COVID-19 vaccine doses, including variant-adapted doses in response to risks and shocks. The $200 million facility is designed to enable countries to protect [...]

Virtusa Delivers COVID-19 Vaccine Tracker

Virtusa Delivers COVID-19 Vaccine Tracker

SOUTHBOROUGH, Mass., March 24 (Korea Bizwire) – Virtusa Corporation today announced that its Virtusa Vax Manager is available to provide businesses with an easy way to track employee vaccination status. The COVID-19 vaccine tracker and return to office capabilities of Virtusa Vax Manager can be built rapidly, and is easily configurable on technology from Pegasystems, the software company that [...]

Men in 20s Struggle with Hair Loss Following COVID-19 Vaccinations

Men in 20s Struggle with Hair Loss Following COVID-19 Vaccinations

SEOUL, Feb. 10 (Korea Bizwire) — Several male recipients of the COVID-19 vaccine are struggling with severe hair loss. A 23-year-old man surnamed Ahn, began experiencing hair loss two weeks after being vaccinated with the second dose of the COVID-19 vaccine by Moderna Inc. last October. The hair loss continued, and after two weeks, his [...]

AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material

AGC Biologics Supports Omicron-based Vaccine Candidate Manufacturing with Starting Material

Heidelberg, Germany, Feb. 8 (Korea Bizwire) – AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility. According to a recent news release from Pfizer and BioNTech, the companies have started to develop an Omicron-based [...]

Gov’t to Offer Up to 5 mln Won in Medical Fee Assistance to Students with Post-vaccine Symptoms

Gov’t to Offer Up to 5 mln Won in Medical Fee Assistance to Students with Post-vaccine Symptoms

SEOUL, Jan. 18 (Korea Bizwire) — The government plans to offer up to 5 million won (US$4,200) in medical fee assistance for treatment of post-vaccination side effects among students, officials said Tuesday, as the country plans to expand the vaccine pass system to include 12- to 18-year-olds in March. According to the education ministry, students [...]

S. Korea Approves Novavax COVID-19 Vaccine

S. Korea Approves Novavax COVID-19 Vaccine

SEOUL, Jan. 12 (Korea Bizwire) — South Korea’s drug safety agency on Wednesday authorized the use of U.S.-based biotechnology company Novavax Inc.’s COVID-19 vaccine. The protein-based vaccine, Nuvaxovid, marks the fifth COVID-19 vaccine to get approval for use here, following the ones by British-Swedish pharmaceutical giant AstraZeneca and Oxford University, Pfizer Inc., Johnson & Johnson [...]

SK Bioscience Extends Manufacturing Deal with Novavax Through 2022

SK Bioscience Extends Manufacturing Deal with Novavax Through 2022

SEOUL, Dec. 24 (Korea Bizwire) — SK Bioscience Co., a vaccine unit of South Korea’s SK Group, said Friday it has extended an agreement to manufacture a component of the U.S.-based biotechnology company Novavax Inc.’s COVID-19 vaccine by one more year. Under the extended agreement, SK Bioscience will reserve additional manufacturing capacity to produce antigen, [...]